The Enterprise Value as of December 2025 (TTM) for Shanghai Henlius Biotech, Inc. (2696.HK) is 33.53B

According to Shanghai Henlius Biotech, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 33.53B. This represents a change of 71.76% compared to the average of 19.52B of the last 4 quarters.

Shanghai Henlius Biotech, Inc. (2696.HK) Historical Enterprise Value (quarterly & annually)

How has 2696.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Shanghai Henlius Biotech, Inc. over the last ten years is 16.19B. The current 33.53B Enterprise Value has changed 20.61% with respect to the historical average. Over the past ten years (40 quarters), 2696.HK's Enterprise Value was at its highest in in the June 2025 quarter at 28.96B. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.

Shanghai Henlius Biotech, Inc. (2696.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Shanghai Henlius Biotech, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Shanghai Henlius Biotech, Inc. (2696.HK) Average Enterprise Value

How has 2696.HK Enterprise Value performed in the past?

The current Enterprise Value of Shanghai Henlius Biotech, Inc. (2696.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Shanghai Henlius Biotech, Inc. (2696.HK) Enterprise Value vs. Peers

How is 2696.HK’s Enterprise Value compared to its peers?

Shanghai Henlius Biotech, Inc.’s Enterprise Value is greater than Genscript Biotech Corporation (3.95B), greater than Simcere Pharmaceutical Group Limited (27.71B), less than Shanghai Junshi Biosciences Co., Ltd. (35.89B), greater than Asymchem Laboratories (Tianjin) Co., Ltd. (25.23B), greater than Livzon Pharmaceutical Group Inc. (25.78B), greater than Duality Biotherapeutics, Inc. (23.87B), greater than China Medical System Holdings Limited (26.35B), greater than Ascentage Pharma Group International (19.01B), less than RemeGen Co., Ltd. (45.85B), greater than Zai Lab Limited (1.43B),

Build a custom stock screener for Shanghai Henlius Biotech, Inc. (2696.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shanghai Henlius Biotech, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shanghai Henlius Biotech, Inc. (2696.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shanghai Henlius Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.